Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, (23), p. S306, 2023
DOI: 10.1016/s2152-2650(23)01070-4
Links
Tools
AML-497 Salvage Treatment With Venetoclax (Ven) and Hypomethylating Agents (HMA) for Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (AML) Patients: Clinical Characteristics and Outcomes
Journal article published in 2023 by
Ahmad Ghorab 
,
Mark Litzow,
Naseema Gangat,
Aref Al-Kali,
Mithun Shah,
Hemant Murthy,
Hasan Alkhateeb,
Kebede Begna,
Mrinal Patnaik,
James Foran,
Talha Badar
,
Mark Litzow,
Naseema Gangat,
Aref Al-Kali,
Mithun Shah,
Hemant Murthy,
Hasan Alkhateeb,
Kebede Begna,
Mrinal Patnaik,
James Foran,
Talha Badar
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 